58.45

2.42% -1.45

After Hours: 58.44 -0.01 -0.02%

Eton Pharmaceuticals Inc (ETON)

Overview News Price History Option Chain Financials Discussions Forecast

Eton Pharmaceuticals Inc stock is traded at $58.45, with a volume of 489.36K. It is down -2.42% in the last 24 hours and up +27.54% over the past month. Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

Previous Close:

$59.90

Open:

$59.87

24h Volume:

489.36K

Relative Volume:

0.91

Market Cap:

$1.67B

Revenue:

$86.93M

Net Income/Loss:

$-1.48M

P/E Ratio:

-824.40

EPS:

-0.0709

Net Cash Flow:

$431.00K

1W Performance:

-2.22%

1M Performance:

+27.54%

6M Performance:

+233.43%

1Y Performance:

+227.08%

1-Day Range:

$56.93

$59.95

1-Week Range:

$56.93

$62.91

52-Week Range:

$14.27

$66.37

Eton Pharmaceuticals Inc Stock (ETON) Company Profile

Name

Eton Pharmaceuticals Inc

Sector

Healthcare (1074)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

(847) 787-7361

Address

21925 W. FIELD PARKWAY, DEER PARK, IL

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

ETON's Discussions on Twitter

Compare ETON vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ETON Eton Pharmaceuticals Inc	58.45	1.71B	86.93M	-1.48M	431.00K	-0.0709
TAK Takeda Pharmaceutical Co Adr	18.45	57.90B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.36	42.89B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.60	43.41B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	75.81	31.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	487.61	22.35B	3.17B	1.29B	1.01B	27.09

Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-23-25	Reiterated	H.C. Wainwright	Buy
Jan-10-25	Initiated	B. Riley Securities	Buy
Jan-06-25	Reiterated	H.C. Wainwright	Buy
Sep-04-24	Resumed	H.C. Wainwright	Buy
May-06-24	Initiated	Craig Hallum	Buy
Oct-14-21	Resumed	B. Riley Securities	Buy
Jan-04-21	Reiterated	H.C. Wainwright	Buy
Sep-20-19	Initiated	B. Riley FBR	Buy
Jun-10-19	Initiated	H.C. Wainwright	Buy

View All

Eton Pharmaceuticals Inc Stock (ETON) Latest News

Sep 06, 2026

118,249 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Bank of New York Mellon Corp - MarketBeat

Sep 06, 2026

Sep 05, 2026

(ETON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Sep 05, 2026

ETON stock holds firm after latest quarter shows steady growth - AD HOC NEWS

Sep 05, 2026

Sep 02, 2026

Sigma Planning Corp Takes Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat

Sep 02, 2026

Sep 01, 2026

PAUL MAIER V At Eton Pharmaceuticals Executes Options Exercise, Realizing $2.84M - Benzinga

Sep 01, 2026

Hsbc Holdings PLC Invests $1.53 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat

Sep 01, 2026

Aug 31, 2026

Eton Pharmaceuticals Director Paul V. Maier Executes Stock Options and Sells Shares on August 28, 2026 - Kalkine Media

Aug 31, 2026

Eton Pharmaceuticals (ETON) director unloads 50K shares after option exercise - Stock Titan

Aug 31, 2026

34,027 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Jefferies Financial Group Inc. - MarketBeat

Aug 31, 2026

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Aug 31, 2026

Deutsche Bank AG Purchases Shares of 26,522 Eton Pharmaceuticals, Inc. $ETON - MarketBeat

Aug 31, 2026

BlackRock Inc. Invests $68.63 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat

Aug 31, 2026

Aug 30, 2026

Navellier & Associates Inc. Makes New Investment in Eton Pharmaceuticals, Inc. $ETON - MarketBeat

Aug 30, 2026